A small randomised controlled trial on ST-MBCT + TAU versus COMET + TAU for patients with a personality disorder
Not Applicable
Completed
- Conditions
- Outpatients with personality disorder(s)Mental and Behavioural Disorders
- Registration Number
- ISRCTN23894653
- Lead Sponsor
- GGZ Delfland
- Brief Summary
2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31556633 (added 27/09/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 58
Inclusion Criteria
1. Patients (male or female) with a main diagnosis on Axis II, meaning one or more cluster A, B, C personality disorders or a personality disorder NOS
2. Aged 18 to 65 years
3. Patients were allowed to have a diagnosis on Axis I other than the exclusion criteria
Exclusion Criteria
1. Acute psychosis
2. Addiction of such severity that clinical detoxification was indicated
3. Severe suicidality for which hospitalisation was necessary
4. Untreated ADHD, bipolar I disorder and an IQ lower than 80
5. Patients were not allowed to have had Schema therapy or COMET in the past 12 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> General psychological distress assessed using the Symptom Checklist-90 (SCL-90; Dutch version by Arrindell & Ettema, 1986). The SCL-90 is a 90-item self-report questionnaire which measures the following complaints: Agoraphobia, Anxiety, Depression, Somatic complaints, Insufficiency of thinking and doing, Interpersonal sensitivity, Hostility, Sleeping problems. The sum score represents a Global Severity Index. The Dutch version is reliable (Cronbach’s alpha 0.97 by total score) and valid (Arrindell & Ettema, 1986). In this study the Cronbach’s alpha for the total score was 0.88. We used the Global severity index (GSI) as primary outcome.<br><br> Method of measurement:<br> Questionnaire (self-assessment)<br><br> Timepoints:<br> T1: Before the start of the therapy<br> T2: Directly after the last therapy session<br> T3: One month after T2<br>
- Secondary Outcome Measures
Name Time Method